Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monosomy 21 in hematologic diseases.

Daniel L Van Dyke1, Anne Wiktor

  • 1Department of Medical Genetics, Henry Ford Health System, 2799 West Grand Boulevard, Clara Ford Pavillion, Detroit, MI 48202, USA.

Cancer Genetics and Cytogenetics
|April 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL).

Leukemia research·2025
Same author

DNA hypomethylation at specific CG-sites within TRAK1 is linked to the neurocognitive profile in Klinefelter syndrome.

Molecular psychiatry·2025
Same author

Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study.

American journal of hematology·2025
Same author

Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.

Leukemia·2024
Same author

Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations.

Cancers·2024
Same author

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL.

Blood advances·2023
Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010
Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010
Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010
Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010
Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010
Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010
See all related articles

Monosomy 21 mosaicism is rare and often an artifact. Further testing, like fluorescence in situ hybridization (FISH), is crucial for confirming true cases and their potential links to leukemia.

Area of Science:

  • Cytogenetics
  • Human Genetics
  • Cancer Genetics

Background:

  • Monosomy 21 mosaicism, a rare chromosomal abnormality, is infrequently reported as an isolated finding.
  • Previous literature describes limited confirmed cases, necessitating rigorous diagnostic approaches.

Observation:

  • Five cases of low-level monosomy 21 mosaicism were identified since 1998.
  • These cases, along with many prior reports, lacked confirmation via fluorescence in situ hybridization (FISH) or follow-up cytogenetics.
  • The observed instances may represent artifacts from cell culture or slide preparation.

Findings:

  • The study questions the validity of many reported monosomy 21 mosaicism cases due to lack of confirmation.
  • Confirmed cases of monosomy 21 mosaicism suggest a potential, though rare, association with acute myelocytic leukemia and chronic lymphocytic leukemia.

Related Experiment Videos

Implications:

  • Future suspected cases of monosomy 21 mosaicism require robust confirmation using advanced techniques.
  • Accurate diagnosis is vital for understanding the true incidence and clinical significance of this chromosomal abnormality.
  • Further research is needed to elucidate the potential oncogenic role of confirmed monosomy 21 mosaicism.